C1ORF107 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.0289005465155E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.30679999998939E-06 |
Normal-vs-Stage2 |
2.056800E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.464220E-02 |
Stage1-vs-Stage2 |
5.634400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.209200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.028200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.19249999874782E-08 |
Normal-vs-AfricanAmerican |
3.876200E-01 |
Normal-vs-Asian |
7.37389999949656E-07 |
Caucasian-vs-AfricanAmerican |
9.167600E-01 |
Caucasian-vs-Asian |
7.073200E-01 |
AfricanAmerican-vs-Asian |
7.200800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.20239999999739E-05 |
Normal-vs-Female |
1.54167999999455E-05 |
Male-vs-Female |
6.509800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.356500E-03 |
Normal-vs-Extreme_Weight |
4.23769999999823E-05 |
Normal-vs-Obese |
4.019400E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.244200E-01 |
Normal_Weight-vs-Obese |
3.007800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.370800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.231700E-02 |
Normal-vs-Age(41-60Yrs) |
8.407600E-04 |
Normal-vs-Age(61-80Yrs) |
4.04990000002492E-06 |
Normal-vs-Age(81-100Yrs) |
3.626600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.335840E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.595700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.872430E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.758600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.472200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.099200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.562600E-01 |
Normal-vs-Grade 3 |
5.400600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.751400E-01 |
Grade 2-vs-Grade 4 |
7.562600E-01 |
Grade 3-vs-Grade 4 |
5.400600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.11600000018974E-07 |
Normal-vs-N1 |
1.209850E-02 |
N0-vs-N1 |
1.197830E-02 |
|
|